title: Capecitabine after gastrectomy for advanced gastric cancer: have we got the patient right?
authors.forename: L
authors.initials: L
authors.lastname: Fornaro
authors.forename: E
authors.initials: E
authors.lastname: Vasile
authors.forename: G
authors.initials: G
authors.lastname: Masi
authors.forename: F
authors.initials: F
authors.lastname: Loupakis
authors.forename: S
authors.initials: S
authors.lastname: Caponi
authors.forename: L
authors.initials: L
authors.lastname: Ginocchi
authors.forename: A
authors.initials: A
authors.lastname: Falcone
mesh_terms: D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D000069287:Capecitabine; D017024:Chemotherapy, Adjuvant; D002986:Clinical Trials as Topic; D003131:Combined Modality Therapy; D003841:Deoxycytidine / Q000031:analogs & derivatives* / Q000627:therapeutic use; D005472:Fluorouracil / Q000031:analogs & derivatives* / Q000627:therapeutic use; D005743:Gastrectomy; D006801:Humans; D013274:Stomach Neoplasms / Q000188:drug therapy* / Q000601:surgery*
chemical_list: D003841:Deoxycytidine; D000069287:Capecitabine; D005472:Fluorouracil